These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1376431)

  • 21. Strategy and planning for chemopreventive drug development: clinical development plans II.
    Kelloff GJ; Crowell JA; Hawk ET; Steele VE; Lubet RA; Boone CW; Covey JM; Doody LA; Omenn GS; Greenwald P; Hong WK; Parkinson DR; Bagheri D; Baxter GT; Blunden M; Doeltz MK; Eisenhauer KM; Johnson K; Knapp GG; Longfellow DG; Malone WF; Nayfield SG; Seifried HE; Swall LM; Sigman CC
    J Cell Biochem Suppl; 1996; 26():54-71. PubMed ID: 9154168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for implementation of large and multiagent clinical chemoprevention trials.
    Meyskens FL
    J Cell Biochem Suppl; 2000; 34():115-20. PubMed ID: 10762023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New opportunities in chemoprevention research.
    Kucuk O
    Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants.
    Singh DK; Lippman SM
    Oncology (Williston Park); 1998 Nov; 12(11):1643-53, 1657-8; discussion 1659-60. PubMed ID: 9834941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NCI cancer prevention and control research.
    Greenwald P
    Prev Med; 1993 Sep; 22(5):642-60. PubMed ID: 8234204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoids in chemoprevention and differentiation therapy.
    Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
    Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of human cancer: a reasonable strategy?
    Meyskens FL
    Recent Results Cancer Res; 1999; 151():113-21. PubMed ID: 10337722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer chemoprevention.
    Lippman SM; Benner SE; Hong WK
    J Clin Oncol; 1994 Apr; 12(4):851-73. PubMed ID: 8151328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiagent chemopreventive agent combinations.
    Brenner DE
    J Cell Biochem Suppl; 2000; 34():121-4. PubMed ID: 10762024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention trials in the cervix: design, feasibility, and recruitment.
    Mitchell MF; Hittelman WN; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong WK
    J Cell Biochem Suppl; 1995; 23():104-12. PubMed ID: 8747384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute.
    Kelloff GJ; Boone CW; Malone W; Steele V
    Basic Life Sci; 1993; 61():373-86. PubMed ID: 8304948
    [No Abstract]   [Full Text] [Related]  

  • 34. Dithiolethiones for cancer chemoprevention: where do we stand?
    Zhang Y; Munday R
    Mol Cancer Ther; 2008 Nov; 7(11):3470-9. PubMed ID: 19001432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in clinical chemoprevention.
    Kelloff GJ; Hawk ET; Karp JE; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
    Semin Oncol; 1997 Apr; 24(2):241-52. PubMed ID: 9129692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarker end-points in cancer chemoprevention trials.
    Boone CW; Kelloff GJ
    IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoids as cancer-preventive agents.
    Sankaranarayanan R; Mathew B
    IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From carcinogenesis to clinical interventions for cancer prevention.
    Greenwald P
    Toxicology; 2001 Sep; 166(1-2):37-45. PubMed ID: 11518609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoids in chemoprevention of head and neck carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.